Perianesthetic Complications in Genetic Mitochondrial Disease: A Review of Case Reports - Scorecard - MDSpire

An Overview of Anesthetic Complications Associated with Genetic Mitochondrial Disorders: Insights from Case Reports

  • By

  • Brittany M. Johnson

  • Simon C. Johnson

  • July 7, 2026

Share

Clinical Scorecard: An Overview of Anesthetic Complications Associated with Genetic Mitochondrial Disorders: Insights from Case Reports

At a Glance

CategoryDetail
ConditionGenetic Mitochondrial Disease (GMD)
Key MechanismsDefects in genes encoding mitochondrial components, leading to hypersensitivity to anesthesia and potential toxicities.
Target PopulationIndividuals with genetic mitochondrial disorders, including rare syndromes like Leigh syndrome and MELAS.
Care SettingSurgical interventions requiring general anesthesia.

Key Highlights

  • GMDs affect approximately 1 in 4000 individuals and exhibit significant clinical heterogeneity.
  • Patients may show profound hypersensitivity to volatile anesthetic agents.
  • Anesthetic exposure in GMD patients can lead to metabolic disruption and severe complications.
  • Case reports indicate a risk of perianesthetic deaths in patients with specific mitochondrial mutations.
  • Clinical diagnosis relies on biochemical studies and overall clinical features.

Guideline-Based Recommendations

Diagnosis

  • Clinical diagnosis based on symptoms and biochemical studies of mitochondrial function.

Management

  • Careful monitoring of anesthetic agents used and patient response during surgical procedures.

Monitoring & Follow-up

  • Assessment of metabolic changes and vital signs during and after anesthesia.

Risks

  • Potential for life-threatening complications including respiratory failure and cardiovascular collapse.

Patient & Prescribing Data

Patients with genetic mitochondrial disorders undergoing general anesthesia.

Sensitivity to anesthetics necessitates tailored anesthetic management strategies.

Clinical Best Practices

  • Utilize total intravenous anesthesia (TIVA) or carefully monitored volatile anesthetic agents.
  • Conduct thorough preoperative assessments to identify potential risks associated with GMD.
  • Implement close postoperative monitoring for metabolic and physiological changes.

Related Resources & Content

Original Source(s)

Related Content